Home » Authors » Trista Morrison

Articles by Trista Morrison

Encysive Tanks On Third PAH Approvable Letter For Thelin

June 19, 2007

By Trista Morrison

NewCo News: Tempo Hurries To Target Nanoparticle Combo Drugs

June 18, 2007

By Trista Morrison

NewCo News: Tempo Hurries To Target Nanoparticle Combo Drugs

June 18, 2007

By Trista Morrison

Optimistic Neurocrine Resubmits NDA For Insomnia Drug Indiplon

June 14, 2007

By Trista Morrison

Optimistic Neurocrine Resubmits NDA For Insomnia Drug Indiplon

June 14, 2007

By Trista Morrison

Coley Acquires TLR7 And TLR8 Programs From 3M For $20M

June 13, 2007

By Trista Morrison

Coley Acquires TLR7 And TLR8 Programs From 3M For $20M

June 13, 2007

By Trista Morrison

Acadia Starts First Phase III For Pimavanserin In Parkinson's

June 12, 2007

By Trista Morrison

Acadia Starts First Phase III For Pimavanserin In Parkinson's

June 12, 2007

By Trista Morrison

NewCo News: Viamet Gets $4 Million Series A For Targeting Metalloenzymes

June 11, 2007

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...